Longaeva Partners »

Benitec Biopharma shares owned by Longaeva Partners

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 125k 10.65

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
RA Capital Management
Nantahala Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Infinitum Asset Management
Siren
Alyeska Investment Group
Silverarc Capital Management
Balyasny Asset Management
Millennium Management

View all funds holding Benitec Biopharma